#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dent's disease Post transplant lymphoproliferative disorder Round cell liposarcoma Lymphoma Pleural mesothelioma Penile cancer Cushing's syndrome Metastatic gastric cancer Chronic graft versus host disease in liver Selective polysaccharide antibody deficiency Piriformis syndrome Pulmonary sarcoidosis Extra-osseous Ewing's sarcoma recurrent Isodicentric chromosome 15 syndrome Stargardt's disease More trials…

    Learn about Rare Diseases

    Glomerulonephritis rapidly progressive Lymphangioma – Trials in Disease Haemophagocytic lymphohistiocytosis Langerhans cell sarcoma – Trials in Disease Crigler-Najjar syndrome – Basic Information Phenylketonuria – Treatment Mucopolysaccharidosis I Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Factor IX deficiency – Trials in Disease MELAS syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Atrasentan Hydrochloride Metamizole Magnesium Ecoo75 Tocilizumab Flutafuranol (18F) ISPAGHULA HUSK NAVENIBART Proline Msv-Allo Adct-402 Eik1003 Mosliciguat Elacestrant Dihydrochloride Batoprotafib Itepekimab Hydroxi-Methionine Calcium Alglucosidase Alfa [11C]Az14193391 Dolutegravir Nacubactam More therapies…

    Learn about Your Condition

    Hairy cell leukaemia recurrent B-cell lymphoma Appendicitis Follicular lymphoma stage IV Connective tissue disorder Coronary artery occlusion Portal hypertension Bronchitis Diabetic gastroparesis Oxygen saturation Diabetic retinal oedema Colorectal cancer Primary myelofibrosis Acne Graves' disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Diffuse large B-cell lymphoma

  • Study on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Pegfilgrastim
    • Golcadomide
    • Betamethasone Sodium Phosphate
    Austria Bulgaria Czechia Denmark Finland France +11

  • Study of Glofitamab and Obinutuzumab for Patients with Relapsed or Refractory Lymphomas After CAR T-cell Therapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Primary mediastinal large B-cell lymphoma
    • Diffuse large B-cell lymphoma
    • Mantle cell lymphoma
    Investigated Drugs:
    • Glofitamab
    • Obinutuzumab
    France

  • Study of Mosunetuzumab and Polatuzumab Vedotin Combination Treatment in Patients with B-Cell Non-Hodgkin Lymphoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Follicular lymphoma
    • Diffuse large B-cell lymphoma
    • Diffuse large B-cell lymphoma recurrent
    Investigated Drugs:
    • Benzocaine
    • Rasburicase
    • Fludeoxyglucose (18F)
    Belgium Spain

  • Study on Lenalidomide, Tafasitamab, and Rituximab for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Tafasitamab
    • Vincristine
    • Cyclophosphamide
    Belgium France

  • Study on Atezolizumab for Patients with High-Risk Diffuse Large B-Cell Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Atezolizumab
    Belgium The Netherlands

  • Study of Loncastuximab Tesirine and Rituximab for Untreated Unfit or Frail Patients with Diffuse Large B-cell Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Adct-402
    • Rituximab
    Italy Spain
Previous Page
1 … 5 6 7 8 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!